With a new CEO at the helm, the Laboratory for Advanced Medicine (LAM) is preparing for the launch of its first liquid biopsy—a blood test designed to detect early-stage liver cancer, expected to win approvals starting in China this year . . .
Home Translational Medicine Biomarkers At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus
- Translational Medicine
- Biomarkers
- Cancer
- Breast Cancer
- China
- GEN Edge
- Liquid Biopsies
- Liver Cancer
- Lung Cancer
- Molecular Diagnostics/In vitro Diagnostics
At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus
Kenneth Chahine, PhD, JD, Discusses Company’s First Liquid Biopsy, Designed to Detect Liver Cancer at Earliest Stages, and Plans to Test for Other Cancers
